Geron Corporation - Common Stock — balance (NASDAQ:GERN)

Financials

Activos totales 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Total de pasivos 59.78 M99.62 M110.58 M146.13 M313.46 M344.67 M Capital total 210.95 M126.42 M80 M247.95 M280.32 M225.87 M Total de pasivos y patrimonio neto 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Deuda total 24.04 M49.83 M51.16 M81.94 M165.37 M119.55 M Deuda neta 24.04 M49.83 M51.16 M81.94 M165.37 M41.99 M

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation - Common Stock

Noticias

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Geron nombra a Timothy Williams como director legal

Geron nombra a Patricia S. Andrews y Constantine Chinoporos para su consejo

Geron añade dos directores con experiencia comercial a su consejo

Geron en la Conferencia de Salud de Barclays: Crecimiento estratégico y planes futuros

Geron en Conferencia de Salud de Barclays: Crecimiento y Planes Futuros

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

Geron en TD Cowen: Crecimiento estratégico y expansión del mercado